← SynDRA
NU-1025
SynDRA canonical compound SYN0049448 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PARP1 |
|---|
| Mechanism of action | DNA dependent protein kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PARP inhibitor
- DNA dependent protein kinase inhibitor
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- GRIN1
- GRIN2A
- GRIN2B
- GRIN2C
- GRIN2D
- GRIN3A
- GRIN3B
Cross-references
Synonyms
- NU1025
- 8-Hydroxy-2-methyl-4(3H)-quinazolinone
- X5ZL2C7V9B
- NSC 696807
- 4(1H)-Quinazolinone, 8-hydroxy-2-methyl-
- CHEBI:75399
- RefChem:854941
- DTXCID40160657
- 8-hydroxy-2-methyl-3-hydroquinazolin-4-one
- 8-Hydroxy-2-methylquinazolin-4(3H)-one
- 8-Hydroxy-2-methylquinazoline-4-one
- 8-hydroxy-2-methyl-1H-quinazolin-4-one
- 8-Hydroxy-2-methyl-3H-quinazolin-4-one
- 8-hydroxy-2-methylquinazolin-4(1H)-one
- MFCD00942555
- 8-HYDROXY-2-METHYL-3-HYDRO-QUINAZOLIN-4-ONE
- 8-hydroxy-2-methyl-3,4-dihydroquinazolin-4-one
- 4pax
- 8-Hydroxy-2-methylquinazolin-4[3H]-one
- NU1
- 4pnm
- Nu 1064
- Tocris-1401
- UNII-X5ZL2C7V9B
- 8-hydroxy-2-methyl-1,4-dihydroquinazolin-4-one
- SCHEMBL215529
- SCHEMBL215530
- orb1300352
- SCHEMBL29529679
- YJDAOHJWLUNFLX-UHFFFAOYSA-N
- GLXC-07345
- HMS3267F20
- HMS3412M16
- HMS3676M16
- HMS3886J17
- BDBM50068774
- NSC696807
- s7730
- AKOS006273983
Look up NU-1025 in the interactive SynDRA portal →